University of Calgary Visual Sciences & Ophthalmology Research Day 2026
Date : May 20, 2026
Time : 15:00
Location : The Glencoe Club (636 29 Ave SW, Calgary, AB T2S 0P1)
TABLE OF CONTENTS
A welcoming message
We are delighted to welcome you to the 2026 University of Calgary Visual Sciences and Ophthalmology Research Day. This annual event serves as a unique forum where ophthalmologists, visual scientists, and biomedical engineers come together to share and discuss the latest scientific and clinical innovations in vision science. It is an opportunity to explore emerging ideas from the laboratory, clinic, and operating room and foster collaboration to advance patient care.
This year, we are honoured to host Dr. David Campbell from the University of Calgary as our guest speaker. is an Internal Medicine specialist with subspecialty training in Endocrinology & Metabolism and advanced expertise in Health Services Research. His work focuses on social disparities and their impact on clinical outcomes in metabolic diseases, using large-scale data and patient-oriented research to improve care for vulnerable populations.
For the 2026 Research Day, we are excited to feature 43 accepted projects, including 16 oral and 27 e-poster presentations. We look forward to your participation in what promises to be an engaging and thought-provoking evening.
In keeping with our commitment to environmentally responsible practices, all posters have been transitioned to an e-poster format, available online at www.UofCResearchDay.com several days before the event. Each e-poster is accompanied by a 2–3-minute video presentation, offering attendees the chance to preview the work and engage in more meaningful discussions during the event.
We extend our sincere gratitude to all presenters for their dedication, creativity, and willingness to share their exciting research. We are also deeply thankful to our panel of judges and session moderators for their valuable contributions in making this event a continued success.
Warm regards,
Dr. Monique Munro – Research Day Co-director
Dr. Abdullah Al-Ani – Research Day Co-director
Program Schedule
- 3:00 – 3:40 PMArrival & E-Poster Viewing
- 3:40 – 3:50 PM Opening Remarks – Dr. Munro&Dr. Al-Ani
- 3:50 – 4:00 PM Calgary Eye Foundation Representative Remarks
- 4:00 – 4:40 PM Guest Speaker – Dr. David Campbell
- 4:40 – 5:50 PM Oral Presentations Part I
- 5:50 PM Buffet Opens – served during presentations
- 6:10 – 7:20 PM Oral Presentations Part II
- 7:20 – 7:40 PM Judge discussion and Networking
- 7:40 – 8:00 PM Concluding Remarks & Awards Presentation
Guest Speaker:
Dr. David Campbell
Associate Professor, Cumming School of Medicine, University of Calgary
Dr. Campbellis an endocrinologist, clinician-scientist, and Assistant Professor at the University of Calgary with appointments in the Departments of Medicine, Community Health Sciences, and Cardiac Sciences. His research focuses on improving health equity and advancing care for individuals living with chronic metabolic diseases, particularly diabetes, through innovative health services and community-based interventions.
Dr. Campbell completed his MD and PhD in Health Services Research at the University of Calgary, following earlier training in kinesiology and medical anthropology. He subsequently pursued subspecialty training in Endocrinology and Metabolism as well as postdoctoral research in inner-city health and health equity. His work examines how social determinants of health influence outcomes in diabetes, obesity, and hypertension, with a strong emphasis on mixed-methods and patient-oriented research.
In collaboration with community organizations in Calgary, Dr. Campbell has developed outreach and screening programs to improve diabetes care among socially disadvantaged populations. Recognized as one of Avenue Magazine’s Top 40 Under 40 in 2022, he has received substantial research funding and authored numerous peer-reviewed publications focused on advancing equitable healthcare delivery.
Research Day Chairs & Moderators
Dr. Monique Munro (Research Day Co-director)
Adult & Paediatric Retina and Uveitis Specialist, Section of Ophthalmology, Department of Surgery, University of Calgary
Dr. Monique Munro is a multi-fellowship trained medical retina and surgical retina specialist who subspecializes in uveitis and pediatric retina. Following medical school and ophthalmology residency in Calgary, she went on to complete a medical retina and uveitis fellowship at the Illinois Eye and Ear Infirmary at the University of Illinois at Chicago. She was then accepted for a competitive surgical retina fellowship at this institution. Dr. Munro has been providing care in the Calgary health region since 2022. She serves on Canadian and international ophthalmology committees and avidly participates in research. She loves to travel to local and international conferences to provide the highest quality, up-to-date, evidence-based care for her patients, and will tack on exploring the area for fun. In her spare time, she likes to read, try restaurants, and spend time with her dog, baby, and husband.
Dr. Abdullah Al-Ani (Research Day Co-director)
Resident Physician, Section of Ophthalmology, Department of Surgery, University of Calgary
Dr. Abdullah Al-Ani completed his undergraduate studies at the University of Victoria, focusing on biochemistry, microbiology, and mathematics. His multidisciplinary interests led him to pursue a PhD in Biomedical Engineering at the University of Calgary, where his research integrated molecular biology, stem cell science, and tissue engineering to develop retinal transplants for degenerative retinal diseases. His doctoral work resulted in several publications and earned multiple prestigious awards, including from the Canadian Institutes of Health Research. He went on to complete the Leaders in Medicine MD-PhD program, graduating with both degrees in 2022, and is currently an ophthalmology resident in Calgary. His long-term goal is to bridge science, engineering, and clinical ophthalmology to drive innovation in eye care. Outside of academia, he enjoys playing soccer, hiking, skiing, and exploring Calgary’s evolving culinary scene.
JUDGES
Dr. Fiona Costello
Professor, Departments of Clinical Neurosciences & Surgery, Associate Dean of Research, Chairs and Professorship, Cumming School of Medicine, University of Calgary
Dr. Costello is a Professor in the Departments of Clinical Neurosciences and Surgery (Ophthalmology) at the University of Calgary and serves as Associate Dean of Research (Chairs and Professorships) at the Cumming School of Medicine. She is also a Clinician Scientist with the Hotchkiss Brain Institute and an internationally recognized neuro-ophthalmologist.
Dr. Costello completed medical school and neurology residency training at Memorial University of Newfoundland before pursuing fellowship training in Neuro-Ophthalmology at the University of Iowa. Since joining the University of Calgary in 2007, she has led a clinical practice focused on disorders affecting the visual pathways and central nervous system.
Her research uses the eye as a model for understanding neurological diseases, including multiple sclerosis and brain tumors, with a strong emphasis on translational vision science. Dr. Costello has held numerous academic leadership roles, including Director of the Office of Surgical Research and Chair of the Roy and Joan Allen Investigatorship for Vision Research. She serves on the editorial boards of several leading journals and has contributed extensively to national and international neurology and neuro-ophthalmology organizations through research, mentorship, and scientific leadership.
Dr. Amin Kherani
CorClinical Associate Professor and vitreoretinal surgeon, Department of Surgery, University of Calgary
Dr. Kherani is a Clinical Associate Professor at the University of Calgary, a vitreoretinal surgeon, and Past President of the Canadian Retina Society. For more than 25 years, he has provided specialized retinal care to patients across Southern Alberta while contributing extensively to ophthalmic education and clinical research.
Dr. Kherani completed his medical degree and ophthalmology residency at the University of Alberta, followed by fellowship training in Medical and Surgical Retina at the University of Iowa. He was the inaugural Residency Training Director for Ophthalmology at the University of Calgary, serving in this role for nearly a decade, and currently serves as Co-Director of the Retina Fellowship Program. He also leads the Office of Surgical Fellowships for surgical trainees at the University of Calgary.
In addition to his academic and educational leadership, Dr. Kherani co-founded Calgary Retina Consultants and helped establish the Southern Alberta Eye Center. His clinical and research interests include vitreoretinal disease and participation in multicentre clinical trials evaluating emerging retinal therapies. Dr. Kherani is widely recognized for his dedication to mentorship, surgical education, and advancing retinal care in Alberta and across Canada.
Oral Presentation Schedule
4:40 PM – 7:23 PM | 8 minutes presentation + 1 minute transition
4:40 – 4:49 PM | Ischemic Optic Neuropathy Associated With Semaglutide: Global Population-Based Analysis Of Over 30 Million Safety Reports | Lakhani M, Al-Ani A, Popovic M, Benard-Seguin E, Margolin E
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed cardiometabolic care; however, recent reports link have linked semaglutide to non-arteritic anterior ischemic optic neuropathy (NAION). We conducted the first global, population-based analysis of over 30 million reports to evaluate formulation-specific risk of ischemic optic neuropathy (ION).
Methods
We deduplicated FDA Adverse Event Reporting System (FAERS) data from December 2017–December 2024. Institutional review board approval and consent were not required for deidentified public data. Semaglutide was analyzed in pooled and brand-specific models (Ozempic, Wegovy). Comparator drugs included metformin, insulin, and tirzepatide. Disproportionality was assessed using reporting odds ratios (RORs, 95% CIs) with Bonferroni correction (p < 0.0056; p < 0.0028 for sex analyses), and Bayesian confirmation (IC₀₂₅ > 0.3), thus minimizing false-positive signals.
Results
Among 30,668,520 reports, 23,678 involved semaglutide (mean age 56.5 ± 11.1 years; 54.1% female). Of these, 3,070 were attributed to Wegovy (mean age 54.7) from 6 countries across 3 continents, and 20,608 to Ozempic (mean age 57.8) from 11 countries across 4 continents. Wegovy demonstrated the strongest signal for ION (ROR = 74.9) versus Ozempic (ROR = 18.8).
Conclusion
Semaglutide was the only agent associated with ischemic optic neuropathy, with the most pronounced signal for Wegovy (ROR = 74.9) followed by Ozempic (ROR = 18.8). Wegovy’s higher dose likely intensifies systemic exposure and accelerates metabolic shifts, predisposing to optic nerve hypoperfusion and impaired autoregulation. The absence of signal for tirzepatide supports a GLP-1–specific, dose-dependent mechanism.
4:49 – 4:58 PM | Histologic Predictors of Functional Success in Müller’s Muscle-Conjunctival Resection: A Quantitative Clinicopathologic Correlation Study | Florido A, Hyrcza M, Kulaga A, Moreau J, Schell C, Punja K
Purpose
To evaluate the histopathological composition of tissues resected during Müller’s muscle -conjunctival resection (MMCR) using the Putterman clamp and to correlate these findings with postoperative functional outcomes.
Methods
Prospective, single-center, clinicopathologic correlation study with eye-level analysis adjusted for within-patient correlation. A total of 159 eyelids from 87 patients were included in the final analysis. Histological evaluation classified specimens according to the presence of smooth muscle (Müller’s Muscle) or absence of identifiable muscle; the single specimen containing both smooth and skeletal muscle was analyzed within the smooth muscle group. Preoperative and postoperative margin-reflex distance 1 (MRD1) values were used to calculate ΔMRD1 as a measure of functional improvement. Associations between ΔMRD1 and histologic findings, resection length, age, and eye laterality were assessed. Linear regression analysis evaluated the relationship between the resection length and ΔMRD1. Generalized estimating equations (GEE) with an exchangeable correlation structure were used to account for inter-eye correlation within patients.
Results
The cohort comprised 87 patients (159 eyelids). The mean age was 68.5 years (SD 14.4 years), and the mean postoperative ΔMRD1 was 1.9mm (SD 1.1mm). Histopathologic analysis demonstrated the presence of smooth muscle in 140 of 159 specimens (88.1%), whereas 19 specimens (11.9%) contained no identifiable muscle. Linear regression demonstrated a significant positive association between resection length and ΔMRD1 (R² = 0.17, p < 0.001), confirming a dose–response relationship between resection length and functional gain. In multivariable GEE analysis, the presence of smooth muscle was independently associated with greater functional improvement. Eyes containing smooth muscle demonstrated a mean ΔMRD1 increase of 1.31 mm compared with eyes without identifiable muscle (β = 1.31; 95% CI, 0.59–2.04; p < 0.001). Age was not significantly associated with ΔMRD1 (β = 0.002 per year; 95% CI, −0.013 to 0.017; p = 0.78), nor was eye laterality (β = 0.15 for right versus left eye; 95% CI, −0.09 to 0.40; p = 0.22).
Conclusion
MMCR performed with the Putterman clamp reliably captures Müller’s muscle in the majority of cases. The histologic presence of smooth muscle is independently associated with greater postoperative eyelid elevation, supporting its functional contribution to surgical outcome. Although functional gain increases with resection length, the modest variance explained indicates that additional anatomical and patient-specific factors influence postoperative response. These findings provide clinicopathologic evidence reinforcing the role of Müller’s muscle in the mechanism of action of MMCR. Comparison of Reference Sticker and Optical Biometry for Standardising Photographic Periocular Measurements.
4:58 – 5:07 PM | Device Dependent Variability in White-to-White and Anterior Chamber Depth and its Impact on ICL Sizing | Alizada A, Alizada A, Abdel-sayyed A, LaBelle M, Al-Ghoul A
To compare white-to-white (WTW) and anterior chamber depth (ACD) measurements from IOLMaster700, Argos, Pentacam AXL, Schwind topography, and digital caliper, and evaluate effects on STAAR OCOS recommended implantable collamer lens (ICL) size and agreement with implanted size.
Methods
Retrospective cross-sectional series of ICL candidates managed by one surgeon Jan 2022–Jan 2025. WTW and ACD were recorded from devices. OCOS sizes were simulated by swapping WTW or ACD while holding the other at the clinic composite standard (WTW=[IOLMaster+Argos]/2−0.34375; ACD=[Schwind+Pentacam]/2) with nonbiometric inputs constant. Device measurements were compared using linear mixed-effects models with eye random intercepts and Tukey-adjusted post hoc tests.
Results
We analyzed 224 eyes (mean age 33.8). Mean WTW and ACD differed significantly between devices (p<0.001). WTW was largest with IOLMaster (12.16±0.37 mm) and smallest with digital calipers (11.81±0.37 mm) and clinic composite (11.73±0.35 mm). Simulated-implanted ICL size agreement was highest with caliper WTW (92.1%) and lowest with IOLMaster WTW (40.8%). Highest interdevice size agreement was between Argos and Schwind (84.7%), while Schwind disagreed with digital calipers in 52.2% of eyes. ACD swaps favored Pentacam (85.6%) and were lowest with Argos (61.9%); Argos measured the deepest ACD (3.82±0.25 mm).
Conclusion
WTW and ACD differed systematically across devices and are not interchangeable for ICL sizing. Caliper-derived WTW paired with Pentacam AXL or Schwind ACD yielded the highest match to implanted length and may increase target-vault rates.
5:07 – 5:16 PM | Seeing What's Missed: Eye Tracking Uncovers Undetected Post-Stroke Vision Impairment in Subacute Rehabilitation | Hill AKF, Kuhl LM, Poitras I, Dukelow SP
Current Canadian stroke best practices recommend vision screening post stroke only when a patient is “at risk of falls”. However, previous work from our group suggests post-stroke vision impairments, including visual fields, attention, and oculomotor dysfunction, are often clinically undetected. Detection of vision impairment is imperative for successful stroke rehabilitation because intact visual function improves rehabilitation outcomes.
Methods:
We used a video-based eye tracking camera during a visual saccade (VSac) and smooth pursuit (VSP) task to assess eye movements in 62 subacute stroke survivors (42 ± 42 days since stroke) and to quantify those with undetected vision impairment. During the VSac task, participants were zinstructed to look at a central fixation target. When the fixation target turned off, they were instructed to look at one of two possible peripheral targets as they appeared (10cm right/left, presentation order pseudorandomized). During the VSP task, participants were asked to track a target moving horizontally (sinusoidal velocity profile). Stroke survivor data was age and sex matched to controls (n=114) to define a normative model and determine impairment. Stroke survivor’s charts were reviewed for record of vision impairment detected during inpatient stay.
Results:
Twenty-one participants had vision impairment (15 oculomotor, 11 fields, 4 attention, 1 both) detected during inpatient stay. Forty-six participants were identified as impaired based on eye-tracking tasks (10 VSac, 17 VSP, 19 both).
Conclusions:
Video-based eye tracking detects more instances of post-stroke vision impairment than are clinically diagnosed and may be a novel tool for identifying candidates for vision-specific rehabilitation.
5:16 – 5:25 PM | Incidence of De Novo Glaucoma and Ocular Hypertension After DMEK vs DSAEK: A Systematic Review and Meta-Analysis | Sadek K, Yu P, Al-Ani A, El-Khoury J, Gooi P; Bhamra J
Purpose
To estimate the pooled incidence of de novo glaucoma and sustained intraocular pressure (IOP) elevation, or ocular hypertension (OHT), in glaucoma-naïve eyes undergoing Descemet membrane endothelial keratoplasty (DMEK) or Descemet stripping automated endothelial keratoplasty (DSAEK), and to compare glaucoma risk.
Methods
Embase, MEDLINE, Cochrane CENTRAL, CINAHL, Web of Science, Scopus, and ProQuest were searched from inception to January 2025. Eligible studies included adult eyes without pre-existing glaucoma undergoing DMEK or DSAEK and reporting de novo glaucoma and/or sustained OHT. Two reviewers independently screened studies, extracted data, and assessed risk of bias. Random-effects meta-analyses pooled single-arm incidences and head-to-head odds ratios. Certainty was assessed using GRADE. The protocol was registered in PROSPERO (CRD420251048130).
Results
Thirty-four studies, including 5,276 eyes (2,490 DMEK; 2,786 DSAEK), met inclusion criteria. Pooled de novo glaucoma incidence was 3% after DMEK and 12% after DSAEK. Sustained OHT occurred in 6% and 26%, respectively. Medication initiation or escalation occurred in 5% after DMEK compared with 17% after DSAEK, while glaucoma surgery occurred in 1% versus 2%. Comparative data from seven studies showed no significant differences between DMEK and DSAEK for glaucoma diagnosis, sustained OHT, or glaucoma surgery. Certainty was low for de novo glaucoma diagnosis and very low for all other outcomes.
Conclusions
De novo glaucoma and sustained OHT are clinically relevant after endothelial keratoplasty and appear less frequent after DMEK than DSAEK. However, comparative evidence remains underpowered and uncertain. Larger head-to-head studies with standardized outcome definitions, explicit steroid protocols, and longer follow-up are needed.
5:25 – 5:34 PM | Combined Ahmed Glaucoma Valve Implantation and Gonioscopy-Assisted Transluminal Trabeculotomy in Advanced Glaucoma: A Retrospective Cohort Study | Bondok MS, Crichton A
To evaluate the efficacy and safety of combined Ahmed Glaucoma Valve (AGV) implantation and Gonioscopy-Assisted Transluminal Trabeculotomy (GATT).
Methods
This retrospective cohort study analyzed eyes with refractory glaucoma undergoing combined AGV and GATT between July 2019 and March 2025. The primary outcome was surgical success per 2025 World Glaucoma Association criteria (IOP ≤21 mmHg and ≥20% reduction from baseline), assessed using Kaplan–Meier survival analysis. Success was classified as complete (no medications) or qualified (with medications). Secondary outcomes included IOP reduction, medication burden, reoperation, and complications.
Results
43 eyes were included, with 84.4% showing advanced visual field loss at baseline (mean MD -20.5 dB) and 32.6% having a history of prior incisional glaucoma surgery. Preoperative IOP was 19.9 ± 6.1 mmHg on 3.1 ± 0.8 medications. At final follow-up, IOP decreased to 12.1 ± 3.0 mmHg on 2.0 ± 1.2 medications. Overall, 81.0% achieved IOP ≤15 mmHg. Kaplan-Meier analysis showed qualified success of 77.1% at 12 months and 66.5% at 24 months, with complete success of 34.4% and 15.4%, respectively. Transient hyphema occurred in 55.8% of eyes, all resolving without complication. One eye (2.3%) required reoperation, and one eye (2.3%) developed delayed onset endophthalmitis at 25 months. No cases of choroidal effusion or hypotony maculopathy were observed.
Conclusions
Combined AGV and GATT provides sustained IOP reduction in advanced glaucoma. Many patients require adjunctive medications, but the valved mechanism may reduce hypotony-related complications.
5:34 – 5:43 PM | Agreement and Clinical Alignment of OSDI and SPEED in a Large Dry Eye Specialty Clinic Cohort | Abdel-sayyed A, Alizada A, Al-Ani A, Al-Ghoul A
Purpose
To compare correlation, agreement, and symptom–sign alignment between the Ocular Surface Disease Index (OSDI) and Standard Patient Evaluation of Eye Dryness (SPEED) in a tertiary dry eye clinic population.
Methods
Baseline adult encounters from 2019 to 2025 were retrospectively analyzed (N = 3,337). Paired OSDI and SPEED totals (N = 3,268) were assessed using Spearman correlation, Bland–Altman agreement after scaling SPEED to 0–100, and Lin’s concordance correlation coefficient (CCC). Internal consistency and exported-total versus item-derived discrepancies were assessed in the item-level subset. Symptom–sign associations were evaluated using FDR-adjusted Spearman correlations. A tear film homeostasis-loss composite (≥2 abnormal among osmolarity, NITBUT, fluorescein staining) was modeled using modified Poisson regression.
Results
OSDI and SPEED were moderately correlated (ρ = 0.53; p < 0.001) but showed poor agreement after rescaling, with a mean bias of 19.6 points, wide 95% limits of agreement (−21.3 to 60.5), and low concordance (CCC = 0.38). Internal consistency was high (OSDI α = 0.89; SPEED α = 0.87), and large scoring discrepancies were uncommon (OSDI >5 points, 1.1%; SPEED >5 points, 0.4%). Objective sign correlations were weak (|ρ| ≤ 0.18). Higher OSDI was associated with homeostasis loss (adjusted PR 1.03 per 10 points; p = 0.001), whereas SPEED was not (adjusted PR 1.00 per 5 points; p = 0.86).
Conclusion
In this dry eye population, moderate correlation between OSDI and SPEED masked clinically relevant individual-level discordance after rescaling, limiting cross-instrument substitution for monitoring. Both questionnaires showed weak correlations with objective signs, supporting multi-domain assessment in dry eye disease.
5:43 – 5:52 PM | Proteomic mapping of the tumor meso-environment decodes the multi-layered biology of uveal melanoma | Dufour A, Lee SH, Sun YJ, Chadha M, Kluding S Velez G, Tang P, Bassuk A, Mruthyunjaya P, Mahajan V
Purpose
Precision oncology seeks a complete biological portrait of a tumor, from its cell-mechanisms to its therapeutic vulnerabilities.
Methods
Here we demonstrate that deep proteomic mapping of a liquid biopsy from patients with uveal melanoma, a deadly eye cancer, decodes this multi-layered biology. Our computational, cellular origin-resolved analysis of multimodal proteomics provides an unprecedented, four-dimensional view of cancer.
Results
It identifies protein signatures that reliably identify tumor cell-types and stratify metastatic risk, while simultaneously revealing the tumor microenvironment’s immunological posture. Beyond this local ecosystem, our TEMPO-chat tool uncovers a dynamic “mesoenvironment” dialogue of bidirectional signaling between the tumor and non-malignant ocular cells that actively shapes cancer progression. Critically, this comprehensive proteomic map also exposes oncogenic pathways and druggable targets in real-time for personalized therapy.
Conclusion
This study establishes that a single proteomic snapshot can deconstruct a tumor’s identity, environment, organ-wide influence, and its actionable targets, offering a new precision paradigm for organ-confined cancers.
5:52 – 6:11 PM Buffet Dinner
6:11 – 6:20 PM | Treatment-Dependent Ocular Biometric Profiles and Refractive Mechanisms in Retinopathy of Prematurity: A Systematic Review and Meta-Analysis | Pham M*, Al-Ani A*, Mikhail D, Alkhawaja M, Hill V, Munro M, Dotchin S *Equal contributions
Purpose
Retinopathy of prematurity (ROP) disrupts normal ocular growth and is associated with early-onset growth myopia. The pattern differs from typical childhood myopia and may vary by treatment modality, though existing evidence is heterogeneous. This study compares treatment groups and evaluates the association between biometric parameters and refractive outcomes.
Methods
A systematic review and meta-analysis were conducted. Seven databases were searched from inception to February 2026. Eligible studies reported biometric and refractive outcomes following pediatric ROP treatment. Random-effects meta-analyses were performed, with pooled mean differences (MDs) calculated.
Results
Thirty-five studies met the inclusion criteria, reporting 5627 eyes. Compared with spontaneously regressed ROP, treated eyes tended toward greater myopia, which was significant for laser-treated eyes (mean spherical equivalent MD, -1.83D), but not for anti-VEGF-treated eyes (mean spherical equivalent MD, -0.28D). Compared with laser, anti-VEGF treatment was associated with significantly lower mean lens thickness (MD, -0.28mm; p<0.001), decreased mean keratometry (MD, -0.99D; p<0.001), deeper mean anterior chambers (MD, 0.16mm; p=0.001), and greater mean corneal thickness (MD, 8.75μm; p=0.03). Mean axial length did not differ significantly between anti-VEGF and laser groups. Biometric outcomes were not significantly different between spontaneously regressed and treated eyes, except for mean anterior chamber depth.
Conclusions
ROP treatment modality was associated with distinct biometric and refractive profiles. Laser treatment is linked to greater myopia compared with anti-VEGF. This difference is unlikely to be driven by axial elongation but may be related to anterior segment configuration, including anterior chamber depth, lens thickness, keratometry, and corneal curvature.
6:20 – 6:29 PM | Bimanual Coordination and Semantic Segmentation of Surgical Instruments in Cataract Surgery Training: A Longitudinal Study | Mikhail D, Xie S, Balas M, Kwok J, Miguel A, RaiA, Rai A, Kertes P, Ahmed I, Schlenker M
To quantify longitudinal bimanual coordination, instrument positioning, and operative field centering during cataract surgery across a resident’s first year of surgical training.
Methods
In this n=1 study, 100 surgical videos spanning a resident’s 6th–760th case were analyzed. Motion tracking and semantic segmentation of instruments, iris, and Purkinje reflex was performed using Meta’s Segment Anything Model 2.0. Assessed metrics included spatial positioning (field centering, radial distance, surgical footprint) and tandem motion parameters (path length, mean absolute speed and angular differences, spatial proximity). Monotonic trends were assessed using Mann–Kendall test with Theil–Sen slope estimation. Associations with case number were evaluated using Spearman’s correlation.
Results
Field centering improved, with Purkinje and iris centroid offsets decreasing by 5.75% (95% CI: [–8.16%, –3.10%]) and 4.86% (95% CI: [–6.79%, –2.90%]) per 10 cases, respectively (P<0.001). Total path lengths reduced for primary (50.2%–77.2%) and assisting (40.5%–62.4%) instruments across all pairings (P<0.001), alongside a 2.93% decline in overall field coverage (P=0.001). Bimanual coordination demonstrated task-specific trajectories. Mean angular difference increased by 8.3% for the phacoemulsification-chopper pair (95% CI: [0.1%, 17.1%], P<0.001). Mean absolute speed difference increased during bimanual forceps use by 18.4% (95% CI: [–3.5%, 45.3%], P<0.05), but decreased for keratome-forceps (–31.8%, 95% CI: [–49.5%, –10.8%], P<0.01) and injector-forceps (–47.2%, 95% CI: [–74.9%, –12.9%], P<0.01).
Conclusions
Computer vision enables precise tracking of surgical skill acquisition. Significant longitudinal improvements in visual axis alignment, motion efficiency, and task-specific bimanual coordination offer an objective framework for competency-based training.
6:29 – 6:38 PM | A Simplified Technique For Intrascleral Haptic Fixation Of Posterior Intraocular Lenses | Zarza V, Olson K, Azarcon C, Williams G
To evaluate visual outcomes, intraocular pressure (IOP) changes, and complication rates after sutureless scleral fixation of posterior chamber intraocular lenses (IOLs) using a simplified Scharioth technique.
Study Design: Single-center retrospective cohort study.
Methods
Consecutive patients who underwent sutureless scleral fixation of a posterior chamber IOL by a single surgeon between 2020 and 2024 were included. The simplified Scharioth technique incorporated three modifications: sclerotomies placed 3.0 mm posterior to the limbus, limbus-parallel scleral tunnels created 2.0 mm from the sclerotomy sites, and construction of intrascleral tunnels for haptic burial using a bent 25-gauge needle. Outcomes included uncorrected visual acuity (UCVA), best-recorded visual acuity (BRVA), IOP, and intraoperative and postoperative complications. Statistical analysis employed chi-square testing and logistic regression.
Results
Sixty-seven eyes of 67 patients (31 males, 36 females; mean age 70.5 ± 13.1 years) were analyzed. At 12 months, mean UCVA improved from 1.10 ± 0.66 to 0.73 ± 0.44 logMAR, and mean BRVA improved from 0.74 ± 0.51 to 0.52 ± 0.36 logMAR. Mean IOP decreased from 17.1 ± 8.3 mmHg preoperatively to 14.3 ± 5.4 mmHg at 12 months. Overall, 37.3% of patients developed at least one postoperative complication; 14.9% required medical treatment and 14.9% required surgical intervention. The most frequent complications were ocular hypertension >25 mmHg (13.1%), IOL decentration or tilt (11.5%), vitreous hemorrhage (9.8%), and IOL dislocation (9.0%). No association was found between complication rates and IOL type (p=0.170) or patient age (p=0.57).
Conclusions
This modified Scharioth technique provided significant visual improvement with acceptable complication rates following scleral IOL fixation.
6:38 – 6:47 PM | Prevalence and associated variables of uveal melanoma referral delays in Alberta, Canada: a retrospective cohort study | Laycock E, Weis E, Cuthbert C, Crump T
Methods: A retrospective chart review of 263 consecutive eligible patients treated for UM at the Alberta Ocular Oncology Program was performed. Data from patients’ electronic medical records were reviewed to extract patient variables and to determine if a referral delay was present. The prevalence of total UM referral delays was calculated, and delays were subdivided into reason for delay, including a) tumours that were detected but not referred to or monitored by a specialist or b) missed tumours. Logistic regressions were used to determine if there were any associations between the collected variables and delayed referrals.
Results: The prevalence of delayed UM referrals was 34%. Preferentially expressed Antigen in Melanoma (PRAME) expression was associated with referral delays. Tumours that were delayed because they were detected but not referred to or followed by a specialist were associated with smaller tumour size. Tumours that were delayed because they were missed were associated with larger tumour size.
Conclusions: Over a third of UM patients experience a referral delay. Risk factors for metastasis, such as large size and PRAME expression, were associated with delayed referrals. Smaller tumours being detected but not referred may imply that primary eye care providers underestimate the malignancy risk of these tumours.
6:47 – 6:56 PM | Cognitive State and Stimulus Type Modulate Readout of Visual Signals | Fadl AK, Cone JJ
Purpose
Visual perception is shaped not only by sensory input, but by the observer’s cognitive state. The primary visual cortex (V1) and superior colliculus (SC) are traditionally associated with feature processing and orienting behaviour, respectively, though emerging evidence suggests a more complex role for the SC. We investigated whether the perceptual role of V1 and SC depends on cognitive state.
Methods
Using an optogenetic technique, very brief (25 ms) randomized light pulses were delivered to V1 or SC of mice to transiently attenuate neuronal activity during a visual detection task, enabling causal assessment of when activity in each region influences perception. A computational modeling framework identified hidden behavioural states from task performance and estimated (at millisecond resolution) how neural suppression in each state affected detection.
Results
The impact of neural suppression on visual detection was state-dependent, with V1 and SC showing distinct contributions. SC involvement was greater in one state, suggesting detection depended more strongly on SC activity. In contrast, V1 contributions remained stable across states. V1 suppression selectively impaired detection of patterned stimuli but not luminance stimuli, while SC suppression impaired both, suggesting cortical and subcortical contributions depend on visual input type.
Conclusion
Internal brain state and stimulus type are determinants of how V1 and SC contribute to visual detection. The same input can yield different perceptual outcomes depending on brain state, with broad implications for visual processing. As circuit-level interventions advance, brain state should be considered a critical variable influencing the efficacy of natural and artificially restored vision.
6:56 – 7:05 PM | The Use of Artificial Intelligence to Predict Postoperative Surgical Outcomes in the Anterior Segment and Ocular Adnexa: A Systematic Review | Alkhawaja M *, Al-Ani A *, Yang L, Mikhail D, Connors L, Milad D, Ambikkumar A, Hill V, Punja K, Costello F, Al-Ghoul A, Gooi P
Purpose
Artificial intelligence (AI) is increasingly applied to support decision-making in ophthalmology. This systematic review evaluates the predictive performance of AI algorithms across anterior segment and ocular adnexal procedures.
Methods
A comprehensive search was conducted across eight databases, including MEDLINE, Embase, the Cochrane Library, Compendex, Web of Science, Scopus, and ProQuest Dissertations and Theses. Studies exclusively investigating AI applications in intraocular lens power calculation formulas and refractive outcomes were excluded. Methodological quality was assessed using the Prediction Model Risk of Bias Assessment Tool (PROBAST).
Results
28 studies (n=2,871,898 eyes) were included. The majority of procedures were of the cornea and external regions (50%), followed by glaucoma (25%), and cataract and oculoplastic procedures (25%). Tree-based algorithms (54%) dominated in representation. 14 studies examined how AI performance compared with traditional prediction paradigms; in 13 (93%), AI outperformed traditional models. Areas under the curve for investigated models ranged from 0.33 to 0.99, reflecting substantial variation. PROBAST assessment found that 71% of studies had a high risk of bias, primarily due to insufficient reporting of model transparency and calibration metrics. Only 11% of included studies incorporated external validation.
Conclusion
AI shows promising prognostic ability in anterior segment and ocular adnexal surgery. AI models generally outperform conventional prediction approaches; however, methodological limitations limit their current clinical translation. Future studies should incorporate external validation, standardized reporting, and assessment of workflow integration to definitively explore the clinical workflow implications of AI integration in surgery.
7:05 – 7:14 PM | Comparison of Yamane Versus Gore-Tex Scleral Fixation for Secondary Intraocular Lens Implantation | Gill K, Alashhab Z, Khaira A, Levasseur SD, Ta Kim DT, Gizicki R
Purpose
To compare visual and complication outcomes between sutureless flanged intrascleral (Yamane) and four-point Gore-Tex–sutured scleral fixation for secondary intraocular lens (IOL) implantation in the largest retrospective cohort to date.
Methods
Retrospective review of 384 eyes undergoing Yamane (n=245) or Gore-Tex fixation (n=139) at a single tertiary retina practice (2019–2024). Baseline characteristics, visual acuity (VA), and complications were analyzed using chi-square/Fisher’s exact and Mann–Whitney U tests; within-group VA change was assessed using Wilcoxon signed-rank testing.
Results
Baseline demographics, ocular history, and preoperative VA were comparable between groups (all p>0.05). Eyes undergoing Yamane were more likely to have prior pars plana vitrectomy (p=0.032). Final VA did not differ between groups (p=0.140), with both demonstrating significant improvement from baseline (p<0.001). Complication profiles differed: Yamane was associated with increased vitreous hemorrhage (p=0.005) and IOL dislocation/subluxation (p=0.003), while endophthalmitis (p=0.003) and suture exposure (p=0.003) occurred exclusively in the Gore-Tex group. Rates of cystoid macular edema, retinal detachment, opacification, and secondary procedures were similar (all p>0.05).
Conclusion
Yamane and Gore-Tex fixation achieve comparable visual outcomes but exhibit distinct complication profiles. Yamane carries higher risk of hemorrhage and IOL instability, whereas Gore-Tex is associated with suture-related complications, including endophthalmitis. These findings support technique selection tailored to patient characteristics and surgical context.
7:14 – 7:23 PM | Sports-Related Traumatic Hyphema and Uveitis in the United States: A 20-Year Epidemiological Analysis | Mikhail D, Milad D, Al-Ani A, Balas M, Bondok MS, Kherani A, Munro M, Kaplan A
Purpose
To characterize the epidemiology, mechanisms, and temporal trends of sports-and projectile-related traumatic hyphema and anterior uveitis presenting to United States (US) emergency departments.
Methods
Retrospective cross-sectional study using the National Electronic Injury Surveillance System (NEISS), 2005–2024. Cases were identified via ocular body-part codes and confirmed through manual narrative review. Eligible diagnoses included traumatic hyphema and AAU. Survey-weighted analyses generated national estimates; temporal trends were assessed using Spearman correlation. Survey-weighted multivariable logistic regression identified predictors of hyphema versus AAU.
Results
Among 1,718 confirmed cases, an estimated 44,563 ED visits occurred nationwide over 20 years. Injuries occurred predominantly in males (80.6%), with a mean age of 20.0 ± 13.3 years. Adolescents aged 10–19 accounted for 51.4% of cases. Traumatic hyphema (50.5%) and AAU (49.0%) were the predominant diagnoses. Gas, air, or spring-operated guns were the most frequently implicated activity (18.6%), followed by soccer (13.9%), basketball (12.2%), and baseball (9.2%). Nonpowder guns (aOR 5.90; 95% CI: 3.49–10.00) and ball or racquet sports (aOR 2.38; 95% CI: 1.60–3.54) were independently associated with increased odds of hyphema compared to uveitis (P<0.001). Projectile mechanisms conferred higher odds of hyphema than non-projectile sports (aOR 3.89; 95% CI 2.50–6.07; P < 0.001). The proportion of these injuries among sports-related ocular trauma increased from 4.1% in 2005 to 13.8% in 2020.
Conclusion
Traumatic hyphema and anterior uveitis affect adolescent males, with projectile mechanisms and ball sports as key contributors. These findings support targeted prevention strategies, including protective eyewear and regulation of high-risk activities.
Accepted Posters
3:00 – 3:40 PM | E-Poster Viewing & Videos Online
View all e-posters and short video presentations at:
www.UofCResearchDay.com
Comparison of Reference Sticker and Optical Biometry for Standardising Photographic Periocular Measurements - Moreau JT, Florido A, Punja KG
Methods: In this retrospective method-comparison study, 100 patients seen in an oculoplastics clinic underwent bilateral WTW measurement using an optical biometer (Zeiss IOLMaster) and digital photography incorporating a blue 10 mm forehead sticker. Agreement between methods was assessed in Python using correlation analysis and Bland-Altman plots.
Results: Mean right-eye WTW was 11.98 ± 0.45 mm with optical biometry and 11.25 ± 0.53 mm with the sticker method. Mean left-eye WTW was 11.90 ± 0.48 mm and 11.31 ± 0.56 mm, respectively. Measurements were strongly correlated between methods (p < 0.0001). Bland-Altman analysis showed a consistent positive bias, with optical biometer measurements exceeding sticker-derived measurements by a mean of 0.73 mm in right eyes and 0.59 mm in left eyes. Conclusions: A 10 mm forehead reference sticker is a practical, low-cost method for standardising digital periocular measurements. Compared with reliance on WTW-based scaling, it may better account for anatomical variability and reduce systematic calibration error in derived periocular measurements.
The Epidemiology of Pediatric Retinal Injuries Presenting to Emergency Departments in the United States - Mikhail D, Al-Ani A, Milad D, Bondok M, Kherani A, Mitchell P, Munro M, Dotchin S
Methods: A retrospective analysis of pediatric ocular trauma (ages 0–17) was conducted using the National Electronic Injury Surveillance System (NEISS) from 2005 to 2024. Cases were confirmed through a narrative review to isolate retinal pathologies. National incidence was estimated using complex survey weighting. Developmental transitions in injury mechanism were evaluated using Rao-Scott chi-square testing and multivariable logistic regression.
Results: Among 171 confirmed cases, an estimated 3,060 ED visits occurred nationwide over 20 years. Injuries predominantly affected males (72.8%), with a mean age of 12.5 ± 3.2 years. Early adolescents (10–14) represented the largest cohort (45.6%). Commotio retinae (26.2%) and retinal detachment (14.9%) were the most frequent diagnoses. Soccer was the most common activity (33.3%), followed by basketball (8.1%), football (7.3%), and baseball (6.3%). A developmental shift in injury mechanisms was observed (P=0.008): injuries in children aged 0-4 were exclusively related to household objects and domestic accidents, whereas soccer predominated among adolescents aged 15–17 (54.9%). Soccer was not associated with an increased risk of retinal detachment compared with other mechanisms (aOR 0.44; 95% CI: 0.09–2.19; P=0.30). Annual incidence did not significantly change over time (ρ=0.30; P=0.20).
Conclusions: Pediatric retinal injuries presenting to EDs are largely sports-related, with soccer as the leading mechanism in adolescents. A clear developmental shift from domestic to athletic injuries suggests that prevention strategies should be age-specific, emphasizing home safety in young children and protective eyewear in youth sports.
Retinal OCT Thickness as a Diagnostic and Prognostic Biomarker in Central Retinal Artery Occlusion: Systematic Review and Meta-Analysis - Alizada A, Bondok MS, Sadek K, Al-Ani A, Bénard-Séguin É
Methods: We searched Ovid MEDLINE, Embase, CENTRAL, and Web of Science through February 3, 2026, for studies reporting quantitative OCT measurements of CRAO. Primary outcomes were CRAO-fellow eye thickness differences, diagnostic accuracy for classifying onset <4.5 hours, and associations between baseline thickness and final best-corrected visual acuity (BCVA). Random-effects meta-analyses pooled differences and correlations. Results: Twenty-three studies including 1,036 CRAO eyes were included. Within 0–7 days, CRAO eyes showed greater thickness than fellow eyes. Central foveal thickness (CFT) was higher by 61.9 µm (95% CI, 39.0–84.8; I2=67.9%; k=7), while central macular thickness (CMT) showed an imprecise increase of 62.8 µm (95% CI, −25.7 to 151.3; I2=63.4%; k=3). Greater baseline thickness correlated with poorer final vision: r=0.39 for CFT and r=0.42 for CMT. Two studies evaluated onset <4.5 hours, with sensitivity of 96.2% and specificity of 91.5%. Conclusions: OCT shows foveal thickening in acute CRAO and moderate, unadjusted associations between baseline thickness and worse visual outcomes. Evidence for thickness-based early-onset classification is promising but limited. Retinal thickness should be interpreted as an adjunctive marker of ischemic injury rather than a stand-alone diagnostic tool.
Evaluating the Need for a Canadian Women in Ophthalmology Mentorship Program: Trainee and Physician Perspectives - Sun Y, Rawlyk B, Holdsworth M, Dotchin S
Methods: An online cross-sectional survey was distributed to female-identifying ophthalmologists and trainees across Canada from October 2025 to January 2026. Survey questions assessed interest in a formal mentorship program, preferences for matching and program format, and priority areas for mentees and mentors. Quantitative data were analyzed using descriptive statistics and Mann-Whitney U tests. Free-text responses were analyzed using thematic coding.
Results: A total of 68 participants provided consent, including 26 trainees and 42 practicing ophthalmologists. Most respondents were from Western Canada (57%; British Columbia, Alberta, Saskatchewan, or Manitoba). Interest in mentorship pairing was high, with 69% of participants responding “yes.” Participants preferred cross-province pairing (74%), check-ins every 2–3 months (45%), and remote or virtual formats (57%). Mentees and mentors reported similar levels of agreement regarding the need for a pan-Canadian mentorship program (p=0.136). However, there was a significant difference between groups regarding ease of accessing meaningful female mentorship (p=0.02).
Conclusions: Canadian women in ophthalmology expressed strong interest in a national mentorship program with flexible matching, virtual meetings, and cross-province pairings. These findings may inform future mentorship initiatives supporting career development, transitions, and work-life integration.
Corneal higher-order aberrations after photorefractive keratectomy versus laser-assisted in situ keratomileusis for myopic correction: a Systematic review and Meta-analysis - Sadek K, Alizada A, Abu Al-Burak S, Ihmouda K, Lee M, Al-Ani A, Popovic M, Chan C
Methods: MEDLINE, Embase, CENTRAL, Web of Science, CINAHL, and PubMed were searched from inception to 2 September 2025 for comparative PRK versus LASIK studies reporting corneal HOA outcomes. Two reviewers independently screened studies, extracted data, and assessed risk of bias using ROBINS-I. Random-effects meta-analyses were performed for total corneal HOA root-mean-square (RMS) and corneal spherical aberration, with prespecified subgroup and leave-one-out sensitivity analyses.
Results: Ten studies met the inclusion criteria. Eight studies (751 PRK eyes and 608 LASIK eyes) contributed to the pooled analysis of induced total corneal HOA RMS, showing a small but significant effect favouring PRK (mean difference [MD] −0.04 μm, 95% CI −0.06 to −0.02; I² = 79%). The effect remained directionally consistent for wavefront-optimized (MD −0.05 μm, 95% CI −0.08 to −0.02) and aspheric/aberration-free profiles (MD −0.09 μm, 95% CI −0.17 to −0.02). Corneal spherical aberration did not differ overall (MD 0.00 μm, 95% CI −0.03 to 0.03; I² = 59%), although excluding outlying Russo 2021 data yielded a small effect favouring LASIK. Vertical coma generally increased more after LASIK.
Conclusions: PRK is associated with a small reduction in induced total corneal HOAs compared with LASIK, although the magnitude of the difference is modest and its clinical significance is uncertain. Spherical aberration appears similar between procedures, while vertical coma may increase after LASIK.
Ophthalmic Health Disparities and Access Among Newcomers to Canada: A Systematic Review and Meta-analysis - Sadek K, Zuberi R, Al-Ani L, Al-Dabbagh A, Bondok MS, McClurg C, Al-Ani A
Methods: Following PRISMA guidelines (PROSPERO CRD42024572584), eight databases were searched from inception to March 2026 for Canadian studies on newcomer populations and ophthalmic care disparities, disease burden, and outcomes. Two reviewers independently screened studies and extracted data, with disagreements resolved by a third reviewer. Risk of bias was assessed using ROBINS-I V2, the Critical Appraisal Skills Program checklist, or the Joanna Briggs Institute Checklist. Qualitative and mixed-methods findings on barriers were thematically synthesized. Screening uptake data were pooled using a random-effects Mantel-Haenszel model; heterogeneity was assessed using I² and τ².
Results: Of 3,800 records, 19 studies met the inclusion criteria, and five contributed to the meta-analysis. Most focused on immigrants and were conducted in Ontario. Access to care was the dominant outcome domain. Key barriers included language and communication challenges, limited health literacy and navigation, financial constraints, and transportation- or time-related barriers. Immigrants were less likely than non-immigrants to undergo vision screening (odds ratio 0.69, 95% confidence interval 0.61 to 0.77). Evidence on ocular disease burden was limited and heterogeneous, though several studies reported unmet eye-care needs and elevated visual impairment among refugee and immigrant populations.
Conclusions: Newcomers face linguistic, financial, and systems-level barriers to ophthalmic care in Canada. Lower screening uptake among immigrants highlights persistent inequities in access. Targeted, culturally informed interventions, including outreach, navigation support, and equitable coverage of vision services, are needed to improve access and outcomes.
Selective Serotonin Reuptake Inhibitor Use and Risk of Retinal Vein Occlusion - Maxwell O, Zeng D, Tao B, Kherani A
Methods: A retrospective cohort study was conducted using the All of Us Research Program database. Adults aged ≥40 years with antidepressant exposure were included: 28,397 SSRI users and 10,520 non-SSRI comparator patients. SSRI exposure required ≥2 distinct prescriptions. Multivariable logistic regression adjusted for age, sex, smoking, hypertension, diabetes mellitus, hyperlipidemia, and glaucoma.
Results: Among 38,917 participants, 216 RVO events occurred: 58 BRVO, 103 CRVO, and 55 unspecified/other RVO diagnoses. RVO occurred in 160 SSRI users (0.56%) and 56 comparators (0.53%). SSRI use was not independently associated with overall RVO (OR 1.12, 95% CI 0.83–1.53, p=0.46). Increasing age (OR 1.07/year, p<0.001), smoking history (OR 1.62, p=0.003), and hyperlipidemia (OR 1.72, p=0.005) were independently associated with RVO. SSRI use was associated with higher odds of CRVO (OR 1.67, 95% CI 1.02–2.72, p=0.041), but not BRVO (OR 1.11, p=0.73). Hypertension was independently associated with BRVO, while smoking, hyperlipidemia, and glaucoma were independently associated with CRVO. Conclusions: SSRI use was not independently associated with overall RVO in this active-comparator cohort. Exploratory subtype analyses suggested a possible association with CRVO, but not BRVO, indicating differing associations across RVO subtypes.
Real-World Outcomes of Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Systematic Review and Meta-Analysis - Mikhail D*, Al-Ani A*, Alkhawaja M, Pham M, Milad D, Munro M, Adatia F, Kherani A * Equal contribution
Methods: This study was prospectively registered (CRD420251174114). MEDLINE, Embase, and Cochrane CENTRAL were searched from inception to January 14, 2026, to identify observational studies reporting on real-world use of pegcetacoplan and avacincaptad pegol. Random-effects meta-analyses were conducted to estimate pooled proportions, mean differences in continuous outcomes for 12-month efficacy, and annualized incidence rates, alongside ROBINS-I and GRADE bias and evidence appraisals.
Results: Eight observational studies (1,879 patients; 2,488 treated eyes) were included. Real-world cohorts demonstrated high baseline disease burden, yielding pooled rates of subfoveal involvement [42.5%, 95% CI (20.1–68.4%); I²: 96.3%], multifocal morphology [55.2%, 95% CI (48.7–61.5%); I²: 0.0%], and concurrent fellow-eye neovascular AMD [43.1%, 95% CI (36.9–49.6%); I²: 0.0%]. At 12 months, pooled absolute GA lesion growth was 0.91 mm² [95% CI (0.60–1.21), I²: 85.7%] and visual acuity declined by 0.07 logMAR [95% CI (-0.096 to -0.044), I²: 28.7%]. Annualized conversion to neovascular AMD was 12.02 events per 100 eye-years [95% CI (10.02–14.44), I²: 18.4%]. Intraocular inflammation risk was 0.32% [95% CI (0.16–0.64%), I²: 0.0%], contributing to an all-cause discontinuation rate of 2.42% [95% CI (1.09–5.30%), I²: 67.5%].
Conclusions: Low-to-very-low-certainty evidence estimates the pooled baseline characteristics, 12-month efficacy, and safety of real-world pegcetacoplan and avacincaptad pegol use. These results may assist ophthalmologists in counseling patients about anticipated outcomes before initiating therapy.
Selective Laser Trabeculoplasty as Primary Glaucoma Treatment in Community Practice - Sabau M, Rawlyk B, Thatcher M D, Campos-Baniak M G
Methods: A retrospective chart review was conducted on 411 treatment-naïve eyes undergoing SLT between 2020 and 2023 in a single community practice in Saskatchewan. Eligible patients had newly diagnosed, untreated primary open-angle glaucoma, ocular hypertension (OHT), glaucoma suspect, or other open-angle glaucoma subtypes. Patients received up to two rounds of 180-degree SLT; data following escalation to additional treatment were excluded. Target IOP was determined per Canadian Target IOP workshop guidelines based on disease severity. Eyes were stratified into success (target reached after one or two SLT sessions), failure after one SLT without retreatment, and failure after two SLTs. ANOVA, chi-square, t-tests, and multivariable logistic regression were used.
Results: SLT achieved target IOP in 245 eyes (59.6%); 126 (30.7%) failed a single session without retreatment, and 40 (9.7%) failed two. Success was associated with younger age (62.7 vs 66.1 years, p=0.016), higher baseline IOP (25.6 vs 22.3 mmHg, p<0.001), OHT, and early disease (both p<0.001). On multivariable regression, moderate (OR 6.15, p=0.001) and advanced glaucoma (OR 8.25, p<0.001), lower baseline IOP (OR 0.82, p<0.001), and greater central corneal thickness (OR 1.007, p=0.026) independently predicted failure. Conclusions: SLT is an effective primary therapy for treatment-naïve glaucoma patients in community practice, particularly those with early disease, OHT, and higher baseline IOP. Advanced severity and lower baseline IOP predict failure.
The State of the Art of Preoperative Management Strategies to Enhance Recovery in Uveal Melanoma - Pham M, Soibelman E, Wandzura A, Campbell P, Weis E, Crump T
Methods: Medline, Embase, and Cochrane were systematically searched from inception to August 2025 for UM clinical guidelines published within the past seven years, supplemented by targeted searching. Eligible guidelines were reviewed for preoperative recommendations. Guidance was categorized by intervention type and graded using SIGN Grading System (1999–2012).
Results: Eight guidelines (2019-2025) met inclusion criteria. Most emphasized non-recovery-focused preoperative management: six (75%) addressed prognostication, and four (50%) addressed cancer staging. These recommendations were deemed Grade A, reflecting directly applicable and overall consistent evidence. Six (75%) guidelines provided no recommendations on interventions intended to enhance recovery. Two (25%) discussed preoperative patient education, psychosocial support, and care coordination, while one (12.5%) also addressed symptom management and nutrition. Recovery-related recommendations were graded as Good Practice Points or Grade D, likely reflecting clinical experience, patient surveys, or limited cited evidence.
Conclusions: Current UM guidelines emphasize survival-focused preoperative management, with limited recovery-focused guidance. Many preoperative care recommendations reflect general best practices across the disease course rather than interventions timed before surgery, warranting research on UM-specific ERAS strategies to improve patient outcomes.
Higher-order aberrations after femtosecond laser-assisted cataract surgery versus phacoemulsification: a Systematic review and Meta-analysis - Thraya A, Sadek K, Saladeen S, Tao B, Al-Ani A
Methods: MEDLINE, Embase, ProQuest, WebofScience, CENTRAL, CINAHL, and Scopus were searched without language or date restrictions for comparative studies reporting wavefront-derived HOA outcomes. Mean differences (MD) with 95% confidence intervals were pooled using a random-effects model. Sensitivity analyses assessed the influence of outlying studies on heterogeneity.
Results: Eleven studies were included. FLACS yielded significantly lower corneal HOAs (MD = -0.11µm; 95% CI: −0.19 to −0.03; P=0.01; I²=42%) and internal HOAs (MD = −0.15µm; 95% CI: -0.26 to -0.03; P=0.01; I²=72%) compared to conventional phacoemulsification. Total ocular HOAs did not differ significantly in the primary analysis (MD = −0.07µm; P=0.11; I²=58%); however, sensitivity analysis excluding a high-leverage outlier yielded a significant reduction with FLACS (MD = -0.09µm; P=0.03). Ocular trefoil was also significantly lower (MD = -0.05µm; P=0.001). Coma and spherical aberration showed no significant differences.
Conclusions: FLACS is associated with a modest reduction in corneal and internal HOAs compared to conventional phacoemulsification; however, these differences do not consistently translate into reduced total ocular aberrations. Modest effect sizes and substantial heterogeneity suggest limited optical advantage for most patients, though benefits may be clinically relevant with premium IOL implantation.
Evaluating the Accessibility of Provider Cards: A Quantitative and Qualitative Exploration into the Patient Experience in Ophthalmology - Kherani I, Armstrong T, Cheema M, Ing E
Methods: Provider card dimensions, font size, leading, and contrast ratios were measured. Anonymized surveys captured patient demographics, visual acuity, and Ishihara colour vision testing. Readability and importance to physician-patient relationship were rated on a visual analog scale. Qualitative responses were analyzed using Braun and Clarke’s thematic analysis.
Results: Forty-one cards were analyzed (mean width 91.43 mm; height 57.46 mm). Mean font size was 2.70 mm (7.68 pt), below the 20/50 Snellen equivalent threshold. The font-to-leading ratio averaged 80%, and mean contrast ratio was 7.51:1, with 37% of cards failing minimum contrast standards. Among 113 respondents, 74% were over 45 and 65% were female, predominantly from glaucoma and neuro-ophthalmology clinics. Mean near visual acuity was 0.14 logMAR (20/30), and 25% scored at test plate or below on Ishihara testing. Mean readability was 8.0/10, though 9% rated cards at 3.0/10 or below. Importance to the doctor-patient relationship averaged 7.6/10, and reliance on cards for follow-up was 6.6/10. Key readability barriers included small font (79%), small card size (49%), and cluttered design (49%). Physician name (94%) and phone number (92%) were identified as the most essential content elements. Qualitative themes emphasized larger font, higher contrast, and minimalist design.
Conclusions: Provider cards are integral to clinical communication and follow-up compliance, yet typographic and design deficiencies limit accessibility. Patient perspectives support foldable, large-font, high-contrast cards with essential information only. Adopting accessible design standards may improve continuity of ophthalmic care.
Prophylactic L‑Arginine Supplementation and the Risk of Retinopathy of Prematurity in Premature Infants Born Before 29 Weeks’ Gestation - Lodha A, Monique M, Stritzke A, Ambikumar A, Carrell N, Kamaluddeen M, Benlamri A, Srivastava O, Mitchell P
Methods: We retrospectively reviewed 28 eyes with prior LASIK or PRK that underwent cataract surgery with LAL implantation at Vector Eye Centre. Preoperative Pentacam densitometry was analyzed by layer and zone, emphasizing total and anterior densitometry in the central 0–2 mm and 2–6 mm zones. Outcomes included uncorrected visual acuity (UCVA), total HOA, coma, spherical aberration, trefoil, and number of LDD treatments at 2 weeks, after final adjustment, and after lock-in. Exploratory Spearman correlations were performed for all, dominant, and non-dominant eyes.
Results: Final dominant-eye outcomes were excellent, with 13/14 achieving 20/20 or better UCVA at lock-in, creating a ceiling effect for final UCVA success. Densitometry was not meaningfully associated with final UCVA. Across all eyes, higher anterior central densitometry correlated with greater LDD treatment burden (anterior 0–2 mm vs number of LDDs: rho=0.389, p=0.041). Exploratory optical-quality signals were observed, including anterior 2–6 mm densitometry correlating with final trefoil (rho=0.375, p=0.049). High total densitometry was also associated with higher trefoil (median 0.101 vs 0.056, p=0.029).
Conclusions: In post-refractive LAL eyes, preoperative densitometry did not predict final visual failure but was associated with adjustment complexity. Future studies should evaluate densitometry-based qualification metrics for LAL and multifocal IOL selection.
Learner-Centred Digital Platforms for Ophthalmology Education: OCTcases 2.0 and Fluxmi - Moreau JT, Sawires K, Pereira A, Kwok J, Yan P
Methods: OCTcases 2.0 was developed through a multi-contributor educational model involving ophthalmology faculty, trainees, and medical students, with a 2026 redesign emphasising accessibility, visual clarity, and learner engagement through a refined website and mobile app. The platform curates real clinical cases, atlas content, and concise teaching resources to support pattern recognition and clinical reasoning. Fluxmi was developed as a complementary self-directed learning tool to reinforce high-yield ophthalmology concepts through structured repeated review of board examination material. Together, the platforms were designed to support resident and medical student education through both image-based interpretation and durable knowledge retention.
Results: As of March 2026, OCTcases contains 171 indexed clinical cases, 151 atlas entries, and 6 foundational OCT articles organised by pathology and learning objective. The redesigned platform expands access across devices and improves learner experience through a modern, intuitive interface. Fluxmi is a new iPhone application for repetition-guided self-study and ongoing review, providing a practical framework for longitudinal reinforcement of board review knowledge. Collectively, these tools address complementary educational needs across undergraduate, postgraduate, and continuing ophthalmic education.
Conclusions: OCTcases 2.0 and Fluxmi represent scalable, learner-centred innovations in ophthalmology education that support self-directed learning, curricular supplementation, and future study of digital strategies to improve knowledge acquisition, image interpretation, and retention among medical students and ophthalmology residents.
Systemic Hormonal Therapies and Retinal and Ocular Vascular Events in Women: A Systematic Review with Meta-analysis - Alkhawaja M *, Al-Ani A*, Pham M, Dotchin S, Munro M
Methods: A comprehensive search was conducted across eight databases from inception to November 2025. Eligible studies investigated women exposed to systemic hormonal therapies, including oral contraceptives, hormone replacement therapy, and selective estrogen receptor modulators or aromatase inhibitors. Risk of bias was assessed using the Newcastle-Ottawa Scale. Random-effects meta-analyses were performed to quantify associations using hazard ratios (HRs) and risk ratios (RRs), analyzed separately.
Results: Seven studies (n≈5.5 million patients, as reported) were included. Pooled estimates found no statistically significant association between oral contraceptive use and retinal artery occlusion (HR 0.99, 95% CI: 0.10-9.52), retinal vein occlusion (HR 1.05, 95% CI: 0.82-1.34), or combined retinal vascular occlusion (RR 1.35, 95% CI: 0.61-2.99) with negligible statistical heterogeneity. However, the largest and most contemporary study (Niazi et al., 2025) reported a significant dose-dependent association between current hormonal contraceptive use and retinal vessel occlusion (AIRR 1.4, 95% CI: 1.1-1.8). Most studies were designated to have a low risk of bias.
Conclusions: These findings reflect a sparse, underpowered, and methodologically heterogeneous evidence base rather than a true absence of association. The dose-dependent relationship identified in the most rigorous available study, situated alongside the recognized prothrombotic mechanisms of exogenous estrogen, supports the need for large, prospective studies with pre-specified outcomes and sex-stratified analyses.
Clinical characteristics, risk factors, and surgical outcomes of secondary macular hole after retinal detachment surgery - Alizada A, Maddigan A, Bhamra J
Methods: A retrospective, consecutive case series was conducted including patients diagnosed with macular hole after retinal detachment surgery between January 2016 and July 2024.
Results: Thirty-two patients were included. The mean interval between retinal detachment repair and macular hole diagnosis was 93 weeks (range: 1–439 months). Several potential associations were identified: epiretinal membrane in 53% (17/32), previous macula-off retinal detachment in 75% (24/32), recurrent retinal detachment in 37% (12/32), and high myopia in 34% (11/32). Primary surgery achieved macular hole closure in 21 of 32 patients, while 11 patients required more than one procedure. Overall anatomical closure was obtained in 87.5% (28/32). Visual outcomes were modest; an improvement of at least two Snellen lines was observed in 43% (14/32) of cases.
Conclusions: Macular hole formation after retinal detachment repair appears to be associated with epiretinal membrane, prior macula-off detachment, recurrent detachment, and high myopia. Although high rates of anatomical closure can be achieved with surgery, functional visual improvement is frequently limited. These findings suggest that mechanisms beyond simple vitreofoveal traction may contribute to macular hole development in previously vitrectomized eyes.
Agreement Between IOLMaster 700 and Pentacam AXL Biometry and Barrett IOL Recommendations in Cataract Surgery Planning - Zarza V, Ali H, Kherani A
Methods: Retrospective paired eye-level analysis of cataract surgery evaluations from March–November 2025. Biometric comparisons included K1, K2, axial length, anterior chamber depth (ACD), white-to-white (WTW), and pupil diameter. Mean paired differences used patient-clustered standard errors and Bland-Altman limits of agreement. Barrett Universal/Toric outputs were compared for IOL power, category, residual astigmatism, and toric model.
Results: Sixty-three eyes (34 patients; mean age 69.2 years) were included; 5 eyes had prior refractive surgery. Keratometry was similar, with no significant K1 or K2 differences. IOLMaster measured longer axial length by 0.036 mm (p<0.001), lower ACD by 0.012 mm (p=0.010), higher WTW by 0.346 mm (p<0.001), and larger pupil diameter by 1.478 mm (p<0.001). In non–post-refractive eyes, Barrett IOL power was similar. Exact IOL power agreement was 38.1%, within 0.50 D was 78.6%, and within 1.00 D was 90.5%. IOL category agreement was high (95.6%, kappa=0.91; n=45). Exact toric model agreement was 62.2%; within-one-step agreement was 92.3%, suggesting most disagreements reflected adjacent cylinder steps rather than different lens families. Conclusions: IOLMaster 700 and Pentacam AXL produced similar Barrett IOL recommendations overall, despite biometric differences. Toric selection was the main discrepancy, likely reflecting small astigmatism-related input differences. Larger studies are warranted.
The Current Need and Cohort Profile of the Alberta Ocular Brachytherapy Program (AOBP) clinical registry and biorepository? - Jhinjar M, Chow E, Pham M, Soibelman E, Wandzura A, Crump T, Weis E
Methods: The AOBP registry and biorepository was developed to provide clinical insights for quality improvement with enough rigor to support scientific research. The goal was to capture patients’ medical history, tumor and genetic profiles, clinical care, and outcomes from referral to death, with some of this data collected via spreadsheets, ad hoc, or not at all. These were consolidated under an approved protocol by the Health Research Ethics Board of Alberta – Cancer Care using University of Alberta’s REDCap (Research Electronic Data Capture) server.
Results: To-date, the AOBP registry has enrolled 932 UM patients. Medical history and clinical care data was extracted for all of those patients; 422 (45%) have had their next-generation genetic sequencing data added; and 444 (48%) have completed at least one patient-reported outcome measure. We recorded 97 (10%) metastatic progressions and 96 (10%) deaths from NetCare.
Conclusions: We developed the AOBP clinical registry and biorepository, capturing comprehensive, standardized data across the patient care continuum while establishing open standards for UM clinical registries, promoting multi-site data collection in the future.
Vitamin A Deficiency and Ocular Manifestations After Bariatric Surgery: A Systematic Review and Meta-analysis - Abdel-sayyed A, Bigam S, Al-Ani A
Methods: MEDLINE, Embase, CENTRAL, Scopus, and Web of Science for studies reporting postoperative vitamin A status or ocular manifestations after bariatric surgery. Primary meta-analysis was restricted to nonpregnant surveillance cohorts with systematic retinol testing and defined thresholds. Pregnancy cohorts and referral-based ocular reports were analyzed separately.
Results: Twenty-seven reports were included. Nine nonpregnant surveillance cohorts (455 participants) contributed to the primary analysis. Pooled vitamin A deficiency prevalence, defined by study-specified low serum or plasma retinol, was 26.1% (95% CI, 18.5–35.4; 95% prediction interval, 10.0–52.8; I² = 71%). Pregnancy cohorts following Roux-en-Y gastric bypass cohorts showed a higher prevalence (61.0%; 95% CI, 51.5–69.8). Night blindness was reported in 60.0% of participants (95% CI, 43.5–74.5; I² = 88%), though assessment was largely symptom-based. Reported ocular manifestations included ocular surface disease, impaired dark adaptation, electroretinographic abnormalities, outer retinal changes, and neuro-ophthalmic findings. Visual dysfunction generally improved following vitamin A repletion (20/23 cases).
Conclusions: Vitamin A deficiency is common after bariatric surgery and may result in a spectrum of ocular complications, particularly night-vision impairment. Risk appears higher in pregnancy and after malabsorptive or revisional procedures. Standardized retinol thresholds and objective assessment of visual function are needed to better define ocular risk and treatment response.
Virtual Reality Perimetry in Children: A Systematic Review of Feasibility, Diagnostic Performance, and Clinical Utility - Lee M, Sharma P, Wesolosky JD
Methods: A systematic review was conducted across Embase, Medline, Scopus, Web of Science, and PubMed to identify studies evaluating VR-based perimetry in children (<18 years). Included studies reported on diagnostic accuracy, reliability, or patient experience. Data extracted included sensitivity, specificity, agreement with SAP, test completion rates, and patient preference. Mixed-population studies were included when pediatric-specific data were limited. Results: Nine studies met inclusion criteria, encompassing predominantly pediatric populations with glaucoma, neuro-ophthalmic disease, or normal vision. VR perimetry demonstrated high feasibility, with completion rates up to 94.9%, consistently outperforming SAP in patient preference and tolerability. Agreement with SAP was moderate to high across studies (e.g., correlation coefficients up to r=0.78), particularly for larger visual field defects. Only one study reported formal diagnostic accuracy, demonstrating high sensitivity (~88.6%) but low specificity (~33.5%). Evidence for reproducibility was limited, with only one study reporting moderate test–retest reliability (ICC ~0.70). Significant heterogeneity existed in VR devices and testing algorithms, contributing to variability in outcomes.
Conclusions: VR perimetry is a feasible and well-tolerated modality for pediatric visual field testing, with moderate agreement with SAP. However, evidence for diagnostic accuracy and reliability remains limited. Further standardized, large-scale studies are required to establish its role in clinical practice.
Shared Developmental Origin and Architectural Divergence in Two Photosensitive Organs: The Eye and Pineal Complex - Heshami N, Bertolesi GE, McFarlane S
Current knowledge of the cellular architect of the pineal complex is limited, a gap that this project aims to address. We used Xenopus laevis larvae at a developmental stage where their pineal complex is functional. We compared and analyzed the eye and pineal complex photosensitive systems that work independently of one another. In this study, we utilized fluorescent in-situ hybridization (FISH), immunohistochemistry (IHC), and advanced 3D analysis via IMARIS, to characterize photosensitive structure. Using established retinal cell-type markers as a reference, we performed a comparative analysis between the eye and the pineal complex. Ultimately, this project will characterize the developing pineal complex structure and define the various pineal cell types and transcriptional relationships with potential retinal homologs.
Characterizing a retinal ganglion cell specific injury model and the regenerative response from single Müller glia in zebrafish - Oshanyk A, Hehr C, and Dr. McFarlane S
Methods: I will use a transgenic zebrafish nitroreductase/metronidazole (NTR/MTZ) to selectively injure RGCs. The timing, extent, and functional consequences of RGC loss will be assessed across developmental stages using histological and functional assays. Next, I will quantify the regenerative capacity of a single MG through lineage-tracing using a photoconvertible reporter Kaede combined with in vivo imaging to track progenitor output following injury.
Results: I have obtained all plasmids required to generate the transgenic RGC-specific injury line. In addition, successful in vivo photoconversion of individual MG using Kaede has been achieved, establishing feasibility for single-cell lineage tracing. Data collection and characterization of RGC ablation and MG-derived regeneration are ongoing.
Conclusions: These preliminary results establish the feasibility of the experimental approach to generate and analyze an RGC-specific injury model and to track MG-derived regeneration at single-cell resolution. Completion of this work will define the characteristics of this injury paradigm and clarify how individual MG contribute to RGC regeneration. These findings will advance understanding for uncovering mechanisms that may be leveraged to therapeutically induce endogenous neurogenesis from human MG to treat neurodegenerative disease.
A Different Kind of Oil Removal - Kherani A
Methods: A representative vitrectomy case presentation for numerous silicone micro droplets from repeated anti-VEGF injectables will be shared. Literature review and summarized recommendations will be discussed to assist vitreoretinal specialists to minimize these risks for their injectable patients.
Results: Majority of commercially available syringes used to administer these IVI are not develop specifically for ophthalmic use, with the syringe inner surface coated with SiO. Factors leading to migration of SiO into the vitreous may include syringe design, needle used, agitation of siliconized syringes and storage. Side effects from SiO migration into the vitreous includes floaters, visual disturbances, inflammatory/immunological responses and elevated intraocular pressure.
Conclusions: Chronic intravitreal anti-VEGF injections may lead to clinically significant accumulation of SiO microdroplets in the vitreous. A SiO free system from vial to eye is imperative to minimize patient morbidity.
The Association Between Visual Impairment and Delirium: A Systematic Review and Meta-Analysis - Abu Osba A, Bondok M, Ibrahim A, Ahmad S, Al-Ani A, Mishra A, Benard-Seguin E
Methods: MEDLINE, Embase, and CENTRAL were systematically searched from inception to September 2025. Title/Abstract/full-text screening, and data extraction were performed by two independent reviewers. Eligible studies included those reporting both visual impairment and delirium. Random-effects meta-analyses were performed to pool odds ratios (ORs). Risk of bias was assessed using the Joanna Briggs Institute (JBI) tools, and the certainty of the evidence was evaluated using the GRADE approach. This review was prospectively registered (PROSPERO; CRD420251269018).
Results: A total of 44 studies involving 26,230 participants were included. Overall, visual impairment was associated with significantly increased odds of delirium (OR 2.40, 95% CI 1.81-3.18; I² = 89.8%). In analyses restricted to studies reporting multivariable-adjusted estimates, this association remained significant (OR 2.02, 95% CI 1.29–3.16; I² = 82.8%). Setting-specific analyses revealed stronger associations in stroke, surgical, orthopedic, and intensive care inpatients, while associations in general medicine and emergency settings were weaker and less precise.
Conclusion: Visual impairment is consistently associated with increased odds of delirium across diverse adult populations and care settings. Identification and management of visual impairment may represent an important component of delirium prevention, including adapting re-orientation approaches to better meet the needs of visually impaired patients. Future studies should evaluate the effectiveness of delirium prevention strategies specifically tailored to individuals with visual impairment.
Redefining Care Pathways: Clinical Outcomes of a Telemedicine Triage Model for Orbit Patients - Huang J, Lim K, Campbell, P, Chow E, Laycock E, Crump T, Weis E, Roelofs K
Methods: 123 patients referred for orbital pathologies were virtually assessed between April 2020 – February 2025. Patient demographics, diagnostic category and the clinical actions taken following virtual assessment were assessed. Patient satisfaction was measured using a Telemedicine Satisfaction Questionnaire (TeSS).
Results: The most common diagnosis was thyroid eye disease (TED) (68 patients, 55.3%). Orbital lesions (OL) (18 patients, 14.6%), meningiomas (5 patients, 4.1%), and a diverse “Other” group of 32 patients (26.0%) consisted of vascular malformations, ocular edema and other inflammatory or structural conditions. Stratified by diagnosis, the mean referral-to-diagnosis time was 60 days for TED, 82 days for OL, 99 days for meningioma, and 34 days for the ‘Other’ group. Across all patients, 59 (46.1%) received CT or MRI from the virtual visit. A high satisfaction rate (89.8%) was shown across all TeSS domains. Most patients (89.8%) felt the tele-orbit model improved their access to specialist care, and 84.7% were satisfied without an in-person physician encounter. 94.9% found the flexible scheduling of telemedicine more convenient than in-person visits.
Conclusion: This tele-orbit program enabled high-yield clinical decision-making and virtual monitoring for orbit patients. This is the first Canadian program to implement structured virtual follow-up for these patients. This program ensures that those with visual consequences are identified early allowing care to be accelerated.
Corneal neurotization with autologous nerve graft: long term patient outcomes - Wandzura A, Madjedi K, Ambikkumar A, Elzinga K, Yau F, Al-Ghoul A, Weis E
Study Design: Prospective Consecutive Case Series
Methods: All patients over a 10-year period 2015-2025 with stage 2–3 NK undergoing sural or medial antebrachial cutaneous nerve autograft CN at a single center were included. Outcomes included corneal sensation, epithelial integrity, visual acuity, and postoperative complications. Data was extracted at standardized postoperative (PO) intervals: POD1, POM1, POM3, POM9, POM12, and most recent follow up. Results were interpreted alongside recent systematic reviews and meta-analyses.
Results: Patients demonstrated improved corneal sensation (19/19), stabilization of epithelial defects (16/19), and visual gains (13/19) where scarring and comorbidity permitted. Vision remained unchanged in (3/19) patients. Our post-operative follow up period ranged from 9-113 months (mean: 42 months; SD: 30 months). Surface healing typically began by 3–6 months postoperatively, consistent with published in vivo confocal microscopy data. No significant differences in outcome were found in the following subgroups: pediatric (2/19), median-antebrachial donor nerve (2/19). Donor-site morbidity was mild. Findings aligned with recent meta-analytic evidence confirming significant improvements in sensation, NK stage, and visual acuity after CN.
Conclusions: Our large, long-term outcomes from a single Canadian center show nerve autograft for CN provides durable reinnervation, with outcomes varying by etiology and timing. Outcomes highlight the overall efficacy, safety and utility of this procedure. CN should be considered a definitive surgical option in patients failing maximal medical therapy or with profound sensory loss.
Call for Abstracts
We invite submissions for the University of Calgary Visual Sciences &
Ophthalmology Research Day 2026.
This event will showcase innovative research from students, trainees,
and faculty across all areas of ophthalmology and visual sciences.
Abstracts will be considered for both podium (oral) and poster presentations
Submission Deadline: April 26, 2026, 23:59 (MST)
Thank You to Our Sponsors
We look forward to welcoming you to this event.
Monique Munro | MD, FRCSC
Abdullah Al-Ani | MD, PhD, PGY-4 Resident
Co-Chairs, University of Calgary Visual Sciences and Ophthalmology Research Day





